Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPO-RA Plus Baricitinib vs. TPO-RA in Patients With ITP
NCT07669675Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2026
- Primary completion
- Dec 2027
01
Overview
A Phase 2 trial of baricitinib in immune thrombocytopenia (ITP), sponsored by Peking University People's Hospital. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
baricitinib
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT07669675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07669675.